Hannover Rück SE (HVRRY)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	36,361	30,140	28,833	23,908	22,925	19,222
Market Cap Growth	23.73%	4.53%	20.60%	4.29%	19.27%	-17.57%
Enterprise Value	40,881	34,252	34,056	27,736	26,923	22,785
PE Ratio	12.48	12.50	14.30	28.65	16.37	17.79
PS Ratio	1.05	1.10	1.01	0.93	0.77	0.68
PB Ratio	2.59	2.29	2.37	2.25	1.58	1.33
P/OCF Ratio	5.88	5.12	4.51	4.52	4.08	5.21
EV/Sales Ratio	1.19	1.25	1.20	1.07	0.90	0.80
EV/EBITDA Ratio	7.04	12.48	12.81	22.10	11.36	13.80
EV/EBIT Ratio	7.17	12.90	13.23	23.50	12.06	15.48
Debt / Equity Ratio	0.35	0.38	0.48	0.55	0.35	0.29
Debt / EBITDA Ratio	0.83	1.80	2.17	4.64	2.13	2.54
Quick Ratio	0.15	0.03	0.03	0.11	0.42	0.42
Current Ratio	0.24	0.10	0.10	0.22	1.10	1.12
Asset Turnover	0.43	0.38	0.40	0.33	0.34	0.33
Return on Equity (ROE)	21.94%	20.22%	17.42%	7.91%	10.57%	7.92%
Return on Assets (ROA)	4.43%	2.33%	2.26%	0.95%	1.59%	1.05%
Return on Capital (ROIC)	18.78%	9.50%	9.17%	4.22%	7.55%	4.98%
Earnings Yield	8.01%	8.00%	7.00%	3.49%	6.11%	5.62%
Earnings Yield	8.01%	8.00%	7.00%	3.49%	6.11%	5.62%
Dividend Yield	2.32%	17.84%	17.40%	17.31%	18.19%	23.37%
Payout Ratio	37.91%	31.07%	33.05%	73.37%	44.07%	54.63%
Total Shareholder Return	2.32%	17.84%	17.40%	17.31%	18.19%	23.37%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.